Biogen stock plummets after it abandons Alzheimer’s drug
March 21, 2019 at 08:04 AM EDT
Biogen lost close to $16 billion from its market cap Thursday after disclosing that it will scrap its most advanced Alzheimer's disease candidate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.